Pure Global

The Effect of Virtual Reality (VR) on Skin Prick Test Related Pain and Fear in Children - Trial NCT06421779

Access comprehensive clinical trial information for NCT06421779 through Pure Global AI's free database. This phase not specified trial is sponsored by Aydin Adnan Menderes University and is currently Recruiting. The study focuses on Pain,Fear,Fear of Pain,Child, Only,Allergy. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06421779
Recruiting
behavioral
Trial Details
ClinicalTrials.gov โ€ข NCT06421779
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
The Effect of Virtual Reality (VR) on Skin Prick Test Related Pain and Fear in Children
A Game-Like Skin Testing Experience: The Effect of Virtual Reality (VR) on Skin Prick Test Related Pain and Fear in Children (A Randomized Controlled Study)

Study Focus

Virtual reality (VR)

Interventional

behavioral

Sponsor & Location

Aydin Adnan Menderes University

Aydin, Turkey

Timeline & Enrollment

N/A

Mar 22, 2024

Jul 01, 2024

50 participants

Primary Outcome

Skin prick test-related pain,Skin prick test-related fear

Summary

This study aims to show the effect of VR on skin prick test-related pain and fear in
 children. We will compare the effect of VR on skin prick test-induced pain and fear in
 children applying to the Pediatric Allergy outpatient clinic with controls who underwent skin
 prick test without the use of VR.

ICD-10 Classifications

Allergy, unspecified
Specific (isolated) phobias
Personal history of allergy, other than to drugs and biological substances
Personal history of allergy to analgesic agent
Other childhood emotional disorders

Data Source

ClinicalTrials.gov

NCT06421779

Non-Device Trial